RESTORIT LTD

Active Oxford

Other human health activities

3 employees website.com
Life sciences and medical technology Other human health activities
R

RESTORIT LTD

Other human health activities

Founded 24 Sept 2019 Active Oxford, England 3 employees website.com
Life sciences and medical technology Other human health activities
Accounts Submitted 18 Jun 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 10 Sept 2025 Next due 23 Sept 2026 4 months remaining
Net assets £-790K £399K 2024 year on year
Total assets £16K £10K 2024 year on year
Total Liabilities £806K £389K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Hampden House Monument Park Chalgrove Oxford OX44 7RW England

Website

www.example.com

Full company profile for RESTORIT LTD (12224117), an active life sciences and medical technology company based in Oxford, England. Incorporated 24 Sept 2019. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

N/A

Net Assets

-£789.62k

Decreased by £398.94k (-102%)

Total Liabilities

£805.90k

Increased by £389.38k (+93%)

Turnover

N/A

Employees

3

Debt Ratio

4951%

Increased by 3339 (+207%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active
Status
Michael Grant WyllieDirectorBritishEngland7524 Sept 2019Active
Sittingbourne Accountancy Services LimitedCorporate-secretaryUnited KingdomUnknown1 Aug 2021Active

Shareholders

Shareholders (1)

Quillitin Pharma Pte
100.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Professor Michael Grant Wyllie

Ceased 30 Mar 2021

Ceased

Quillitin Pharma Pte Ltd

Ceased 9 Mar 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Sept 2025Confirmation StatementConfirmation statement made on 9 Sept 2025 with no updates
18 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
30 Sept 2024AccountsAnnual accounts made up to 31 Dec 2023
10 Sept 2024Confirmation StatementConfirmation statement made on 9 Sept 2024 with no updates
14 Sept 2023Confirmation StatementConfirmation statement made on 9 Sept 2023 with no updates
10 Sept 2025 Confirmation Statement

Confirmation statement made on 9 Sept 2025 with no updates

18 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

30 Sept 2024 Accounts

Annual accounts made up to 31 Dec 2023

10 Sept 2024 Confirmation Statement

Confirmation statement made on 9 Sept 2024 with no updates

14 Sept 2023 Confirmation Statement

Confirmation statement made on 9 Sept 2023 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 9 Sept 2025 with no updates

7 months ago on 10 Sept 2025

Annual accounts made up to 31 Dec 2024

10 months ago on 18 Jun 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 30 Sept 2024

Confirmation statement made on 9 Sept 2024 with no updates

1 years ago on 10 Sept 2024

Confirmation statement made on 9 Sept 2023 with no updates

2 years ago on 14 Sept 2023